RCIAF
ROGERS COMMUNICATIONS INC
$37.80
0.00%
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
Apr 23, 2026
SEC
Rogers Communications held its Annual General Meeting of Shareholders, where all director nominees were elected and KPMG
6-K — Impact 3/10
Apr 22, 2026
SEC
Rogers Communications reported strong Q1 2026 results with 10% revenue growth and 5% adjusted EBITDA growth, driven by a
6-K — Impact 7/10
Apr 22, 2026
SEC
Rogers Communications declared a quarterly dividend of 50 cents per share on its Class A and Class B shares, payable Jul
6-K — Impact 3/10
Analyst Ratings
3Strong Buy
15Buy
5Hold
2Sell
0Strong Sell
Latest Reports
NEUTRAL
6-K
3/10
Rogers Communications held its Annual General Meeting of Shareholders, where all director nominees were elected and KPMG
Apr 23, 2026
BULLISH
6-K
7/10
Rogers Communications reported strong Q1 2026 results with 10% revenue growth and 5% adjusted EBITDA growth, driven by a
Apr 22, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 3 neutral. Avg impact: 4.5/10.
NEUTRAL
6-K
3/10
Rogers Communications held its Annual General Meeting of Shareholders, where all director nominees w
Apr 23, 2026
BULLISH
6-K
7/10
Rogers Communications reported strong Q1 2026 results with 10% revenue growth and 5% adjusted EBITDA
Apr 22, 2026
NEUTRAL
6-K
3/10
Rogers Communications declared a quarterly dividend of 50 cents per share on its Class A and Class B
Apr 22, 2026
NEUTRAL
6-K
5/10
Rogers Communications Inc. issued $750 million in 6.875% Fixed-to-Fixed Rate Subordinated Notes due
Mar 27, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 72% buy across 25 analysts — 3 strong buy, 15 buy, 5 hold, 2 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $5.5B | 6.1% | — |
| Next Q 2026-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $5.4B | 1.1% | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $22.5B | 3.8% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $22.8B | 1.3% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 15 | 5 | 2 | 0 | 72% | |
| May 1, 2026 | 3 | 15 | 5 | 2 | 0 | 72% | |
| Apr 1, 2026 | 3 | 13 | 5 | 3 | 0 | 67% | |
| Mar 1, 2026 | 3 | 13 | 5 | 3 | 0 | 67% | |
| Feb 1, 2026 | 3 | 14 | 5 | 3 | 0 | 68% | |
| Jan 1, 2026 | 4 | 14 | 5 | 2 | 0 | 72% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.